| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
136 |
132 |
$823K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,816 |
1,749 |
$215K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,671 |
1,651 |
$147K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
956 |
935 |
$106K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
779 |
779 |
$99K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
13 |
13 |
$43K |
| 88342 |
|
631 |
626 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
541 |
535 |
$37K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
274 |
274 |
$25K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
128 |
128 |
$13K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
92 |
90 |
$11K |
| 99215 |
Prolong outpt/office vis |
71 |
71 |
$9K |
| 96415 |
|
174 |
169 |
$5K |
| 99205 |
Prolong outpt/office vis |
24 |
24 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
31 |
13 |
$1K |